SynthesisJournal of thrombosis and thrombolysis2020

Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis.

Safi U Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.